Arlindo Lemos Junior has been working in endovascular procedures since 1991, when he first participated in an iliac artery stent in Bellvitge Hospital, Barcelona - Spain. Since then he developed his expertise and passion in acquiring new techniques in the Field. He has been studying Congestion Pelvic Syndrome for more than 10 years, when he was introduced to Dr.J.Leal Monedero from Madrid - Spain. Since then, he become interested in learning the physiopathology, diagnosis and treatment of Compression Vein Syndromes, such as common iliac vein and left renal vein ones, better known as May-Thurner Syndrome and Nutcracker Syndrome. The association of Recurrent Varicocele and Renal Vein compression is described in several papers in the Literature, many urologists do not have comprehension about the hemodynamic aspects of vein flow and reflux.

Endovascular procedures,Congestion Pelvic Syndrome .

amien Byas is the President, North American Scientific Committee on Cardiovascular Health, USA as well as an Epidemiologist and Professor of Public Health, American Public Health Association, International Public Health Delegate, USA.

Cardiology, Cardiovascular Diseases, Epidemiology

Dr. Beder was graduated from La Plata University, School of Medicine, and I was completed Cardiology training at Hospital Interzonal General de Agudos San Juan de Dios, La Plata, Argentina. I'm staff of Cerhu Clinic and Chief of Cardiology of Italia Clinic in San Luis, Argentina, and I completed training in echocardiography and nuclear medicine. I was involved in many educational programs as a Teacher and Director. Some of those programs for echocardiographers in training. I'm Professor in Physiology, Physiopathology and Internal Medicine at Facultad de Medicina, Universidad Católica de Cuyo, San Luis, Argentine. I'm cardiologist at Argentinian Federation of Cardiology and Argentinian Society of CArdiology. I've published original researches in local journals. I've been invited as a guest lecturer in the most Scientific Sessions of the Argentinian Federation of Cardiology since 1996. I was president of San Luis Society of Cardiology in 2007. I was a President from National Congress of Cardiology in 2014

Cardiology, Cardiovascular Diseases

Aris Lacis, cardiac surgeon, professor, MD, PhD graduated Riga Medical Institute in 1961. General and thoracic surgeon in P. Stradina University Hospital in Riga (1964–1969). Thoracic and cardiac surgeon in the Latvian Centre for Cardiovascular Surgery (1969–1994). Since 1994 until 2012 – the head of Pediatric Cardiology and Cardiac Surgery Clinic in University Children’s Hospital, Riga; since 2012 – a consulting professor of this Clinic. Vicepresident of Latvian Society for Cardiovascular Surgery. President of Latvian Association for Pediatric Cardiologists. Author of 395 scientific publications, 3 monographs and 13 patents. Investigator in more than 10 clinical trials including cardiosurgical procedures performed under deep hypothermia, hybrid procedures etc. In May 2009 have been used transcutan intramyocardial delivery techniques for treatment (idiopathic dilated cardiomyopathia) the first 3 months aged patient in the world with autologous bone marrow derived progenitor cells. In November 2010 the first patient with end stage pulmonary hypertension received intrapulmonary implantation autologous stem cells.

Pediatric Cardiology, Cardiovascular Surgery

Michiaki Nagai has completed his graduation from the Jichi Medical University School of Medicine and has been engaged in the Cardiovascular Medicine. Using volumetric analysis in MR SPGR imaging, he has been investigating the fields for target hypertensive organ damages including the relationships among hypertension, blood pressure variability, brain atrophy, cognitive impairment and central autonomic nervous system including the insular cortex. He was engaged in the Interventional Cardiology at Hiroshima City Asa Hospital as the Vice Director. He won the Japanese Society of Hypertension Award in the International Society of Hypertension 2006, the Young Investigator’s Award in the 8th Japanese Neurocardiology Workshop 2007 and Young Scientist Award in the second annual scientific forum of clinical hypertension of the Japanese Society of Hypertension 2013.

Hypertension, Interventional Cardiology, Cardiovascular Medicine

Carola Förster has a convincing track record in (neuro)physiology with a strong focus on the (dis)functions of the blood-brain barrier (BBB). A significant aspect of her research is related to regulation of gene expression at the BBB, specifically by non-coding RNA, particular microRNA, to offer pharmacological solutions to the observed BBB alterations. For this, CF systematically studies the mechanisms from gene regulation, through transcription, to protein degradation and cellular morphology, linking basic science with clinical aspects. After years of experience in research, evaluation, teaching and administration both in hospital and education institutions, CF developed different in vitro and in vivo models of cerebrovascular disease and established recently a division of computational model to further strengthen this area of research.

heart failure and stroke, neurophysiology

Mary Shibuya is an experienced native English medical editor/writer of 32 years living in Japan with a background in chemistry and allergy research at Mayo Clinic (Rochester, MN). For 23 years she was the language editor of the journal Internal Medicine, published by the Japanese Society of Internal Medicine. In addition to editing and preparing research articles for publication in international journals, she attended various medical/scientific congresses as Press (interviews, transcription, summarizing). She also enjoys lecturing on scientific medical writing in English to graduate schools and pharmaceutical companies. She strives to encourage ESL doctors/researchers to publish in English.

allergy research,chemistry,scientific medical writing

Dr. Hallak is currently Chief of Interventional Cardiology Department at American Hospital Dubai, President (gulf Chapter) of international Society of Endovascular Specialists, Chairman of 4TS international conference, and previous Board Member of Emirate Cardiac Society. Dr. Hallak received his post graduate training and research in United States at University of Illinois, Chicago, North Western University and Louisiana University in New Orleans. He is Board Certified in Interventional Cardiology, Cardiovascular Disease, Vascular Medicine, Endovascular Medicine, Nuclear Cardiology and Internal Medicine. He was the Head of Cardiology Department at Saint Francis Hospital in USA, and assistant Professor at LSU New Orleans and University of West Virginia. He has performed thousands of procedures including Cardiac and Peripheral Vascular Intervention in addition to Pacemaker and ICD/ CRT Implantation. He participated in many national and international research studies with many publications. He involved extensively in local, regional and international cardiology conferences as a Speaker and as a Chairman.

Interventional Cardiology, Cardiovascular Disease, Vascular Medicine, Endovascular Medicine, Nuclear Cardiology and Internal Medicine

Dr. Ellahham has served as Chief Quality Officer for SKMC since 2009. In his role, Dr. Ellahham has led the development of a quality and safety program that has been highly successful and visible and has been recognized internationally by a number of awards. As Chief Quality Officer and Global Leader, Dr. Ellahham has a focus on ensuring that that implementation of this best practices leads to breakthrough improvements in clinical quality and patient safety.

Cardiovascular Research

Galya Naydenova Atanasova completed her Ph.D. training in Cardiology from Department of Cardiology, Pulmonology and Endocrinology at Pleven Medical University, Bulgaria. She is a Cardiologist, Assistant Professor at the Department of Internal Medicine, Medical University, Pleven. She is a General Practitioner in Pleven. She specialized in Cardiology from Pleven Medical University during 2015, and General Medicine from Pleven Medical University, Bulgaria during 1993. She has attended to many International Events and presented her research work. She did many researches on metabolic syndrome and myocardial infarction of heart.

metabolic syndrome and myocardial infarction of heart

Dr. Satoru Takeno graduated from Akita University in 2001. After completing the residency program at the International Medical Center of Japan, he started his career as a pediatric cardiologist at Kyoto University Hospital. Since 2011, he has been engaged in pediatric electrophysiology and catheter ablation at Kindai University.

Pediatrics, Pediatric Electrophysiology

Dr. Hany Eteiba MD FRCP(Glas.) FRCP(Edin.) FACC FSCAI FIACS Associate, Consultant Cardiologist, Regional and National Medicine-Director, Associate Medical Director, West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Glasgow Royal Infirmary. He is the Medical Director - Regional and National Medicine Consultant Interventional Cardiologist, West of Scotland Heart & lung centre, Golden Jubilee National Hospital Glasgow Royal Infirmary Honorary Clinical Senior Lecturer, Glasgow University Fellow of the Royal College of Physicians and Surgeons of Glasgow. Dr Eteiba is also a member of the Royal College of Physicians of Edinburgh, member of the American College of Cardiology, member of the American Society for Cardiovascular Angiography and Interventions, Elected Council member of RCPSG and Medical Advisor of the International committee of Glasgow Royal College of Physicians and Surgeons.

Interventional Cardiology, Heart disease, Heart failure

Guy H Fontaine has made 17 original contributions in the design and the use of the first cardiac pace makers in the early 60s. He has serendipitously identified ARVD during his contributions to antiarrhythmic surgery in the early 70s. He has developed the technique of Fulguration to replace surgery in the early 80s (technique used during 30 years in Paris). He has been one of the 216 individuals who have made a significant contribution to the study of cardiovascular disease since the 14th century, one of the 500 greatest geniuses of the 21th Century (USA Books), one of the 100 Life Time Achievement (UK Book). He has more than 900 publications including 201 chapters in books.. He is the reviewer of 26 scientific journals both in basic and clinical science. He served as a member of the Editorial Board of Circulation for 5 years, after reviewing articles for this journal during decades. He has given 11 master lectures of 90 minutes each in inland China in 2014. He has recently developed new techniques of hypothermia for brain protection in OHCA and Stroke. This technique has been fortuitously used after resuscitation of his wife at home in June 2011 with absolutely no neurologic deficit despite 6 minutes of no flow. He has also invented a high-tech device which can be considered the ultimate in palliative care by preventing unexpectedly awaking after ordinary sleep. This device was mostly designed for major neurologic disorders.

cardiovascular diseases, Antiarrhythmic Surgery, Stroke, Neurologic disorders

Dayi Hu is the President of the Chinese Society of Cardiology (CSC), President of the China Committee of Cardio-Cerebral-Vascular Diseases of GSC, a past president of the Chinese College of Cardiovascular Physicians (CCCP), Chief of the Intervention Centre at Peking University People’s Hospital, Dean of Clinical Research Institute at Shanghai’s Fudan University and a member of The International Academy of Sciences for Europe and Asia(IASEA). Professor Dayi Hu is a member of the Board of Directors of the International Society of Cardiovascular Pharmacotheraphy (ISCP), the editor-in-chief of Chinese Journal of Cardiology, an international board member of Journal of Clinical Cardiology, Journal of the American College of Cardiology, European Heart Journal, Nature Cardiovascular Medicine and also many other national and international medical journals. Professor Hu has been the editor-in-chief or major translator of 50 professional books, three of which have been published in United States.

Cardiology, Cardiovascular Pharmacology, Cardio-Cerebral-Vascular Diseases

He graduated from Osaka university Medical School in 1966 and joined a research group of Lipid Research Laboratory at Osaka University in 1969. He became Professor of the second Department of Internal Medicine of Osaka University in 1991 until 2003 when he moved to Sumitomo Hospital as Director and Emeritus Professor of Osaka University. He has long worked on hyperlipidemia and obesity. He has discovered several novel disease entities such as "Autoimmune hyperchylomicrolemia" and "HyperHDLcholesterolemia caused by CETP deficiency"　He was also interested in body fat distribution with respect to morbidity. He developed the method for fat analysis using CT scan and established the concept named visceral fat syndrome in which cardiovascular risks cluster by visceral fat accumulation. He also investigated biological characteristics of adipose tissue and found that adipose tissue abundantly expressed bioactive substances. (Gene 190:227, 1997, Nature Med 2: 800, 1996) During these works, he discovered "adiponectin" which may be one of key players in the mechanism of obesity-related diseases. He is currently President of International Atherosclerosis Society.

Atherosclerosis, Obesity-related diseases , Cardiovascular Diseases

Dr. Santoso Karo Karo MPH, SpJP (K) FIHA ,FAsCC was born on October 1,1945 at present he is the Chairperson of PERKI Foundation, Consultant Cardiologist, Parliament Health Service, Teaching Staff, Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia. He is the part of many organizations as Member,Indonesian Medical Association, Past President, Indonesian Heart Association (PERKI), Chairperson, Board of Ethics, Indonesian Heart Association (PERKI), Co-founders, Indonesian Society of Hypertension (InaSH), Co-founders,Asia Pacific Society of Hypertension (APSH)

Clinical Cardiology, Cardiovascular Medicine, Hypertension

Haruki Okamura Hyogo College of Medicine Japan

Cardiology, Tumor Immunology and Cell Therapy

Dr Antonia Anna Lukito is Interventional consultant cardiologist at Siloam Karawaci Hospital and currently Head of Cardiovascular Department in Pelita Harapan University, and also an Independent Consultant of MRIN Ethics Committee. Dr Antonia joining several overseas formal courses such as Advanced Cardiology Course at Victoria Heart Center Melbourne in 1996, Cardiovascular CT Training at Cologne Germany in 2005, Carotid Intervention Training at NTUH Taipei 2012, Optical Coherence Tomography(OCT) Training at Finlandia 2012, and Rotablator & IVUS hands-on training at Japan in 2013. She also actively involved in Indonesian Heart Association (PERKI) as vice chairman of Indonesian Heart Consumer Cooperatives (KKJI), chairman of Woman Cardiology working roup, and as scientific & education committee in IHA Banten chapter. Dr Antonia also active in Indonesian Society of Hypertension (InaSH), Indonesian Heart Rhythm Society (InaHRS), and Indonesian Society of Interventional Cardiology (ISIC).

Interventional Cardiology ,Hypertension, Cardiovascular Research

1. Mary Shibuya is an experienced native English medical editor/writer of 32 years living in Japan with a background in chemistry and allergy research at Mayo Clinic (Rochester, MN). For 23 years she was the language editor of the journal Internal Medicine, published by the Japanese Society of Internal Medicine. In addition to editing and preparing research articles for publication in international journals, she attended various medical/scientific congresses as Press (interviews, transcription, summarizing). She also enjoys lecturing on scientific medical writing in English to graduate schools and pharmaceutical companies. She strives to encourage ESL doctors/researchers to publish in English.

allergy research,chemistry,scientific medical writing

Bambang Budiono has his expertise in interventional cardiology for 15 years. He has a lot of clinical experience and involved in some international registration and trials. His interest and expertise in interventional cardiology is well known, which make him invited as faculty in a lot of regional and international meetings.

Interventional cardiology, Heart Diagnosis

Dr. Robaayah Zambahari is known for her extensive experience in cardiology, both locally and internationally. Dr Robaayah is CEO and managing director of the National Heart Institute (IJN) in 2009. She pursued medicine at University of Malaya in 1977 and received speciality training at the Academy of Medicine of Malaysia. She was appointed senior consultant cardiologist and head of department at IJN in 1992. She is a member of Royal College of Physicians of Glasgow, the Royal College of Physicians of London, and the American College of Cardiology, Emeritus member of the Asia Pacific Society of Interventional Cardiology , FAPSIC, October 2006, Member of the National Heart Association of Malaysia, Member of the ASEAN Federation of Cardiology.

Clinical research in cardiology,Interventional Cardiology,Development of Evidence-based Clinical Practice Guidelines

Prof. Rui M. S. Almeida is Portuguese, born in Inhambane, Mozambique, and started medical school in Lisbon (Portugal). Received medical degree from the Parana Federal University - Brazil, in 1980. Rui Manuel de Sousa Sequeira Antunes de Almeida is the board member of the Paraná’ Society of Cardiovascular Surgery, since 2002, and became its President (2006-08). Was elected President of the South Brazilian’ Society of Cardiovascular Surgery (2007-09), a Member of the Board of the Brazilian’ Society of Cardiovascular Surgery (2009-2010), President of the Board (2011-2013) and President of the Endovascular Department of the Brazilian’ Society of Cardiovascular Surgery (2011-2013), Scientific Director of the Brazilian’ Society of Cardiovascular Surgery (2014-15) and Vice-President for the period of 2016-17. As an active member of the Brazilian Society of Cardiovascular Surgery, has represented it in meetings with the Medical Brazilian Association, the European Association of Cardiothoracic Surgery, the World Society of Cardio-Thoracic Surgeons, in which is the delegate for Brazil, and other international and national medical societies. He has published more than 100 papers in peer reviewed national and international, medical journals and presented more than 250 papers in scientific meetings. Was invited to lecture at specialized meetings more than 100 times, in Brazil, Argentina, Canada, China, Croatia, France, Greece, Italy, Portugal, Slovenia, Spain, Sweden, United Kingdom and United States of America. He is also part of the editorial board of ten international journals and five Brazilian.

Cardiovascular Surgery ,Cardiothoracic Surgery

Dr. Beder was graduated from La Plata University, School of Medicine, and I was completed Cardiology training at Hospital Interzonal General de Agudos San Juan de Dios, La Plata, Argentina. I'm staff of Cerhu Clinic and Chief of Cardiology of Italia Clinic in San Luis, Argentina, and I completed training in echocardiography and nuclear medicine. I was involved in many educational programs as a Teacher and Director. Some of those programs for echocardiographers in training. I'm Professor in Physiology, Physiopathology and Internal Medicine at Facultad de Medicina, Universidad Católica de Cuyo, San Luis, Argentine. I'm cardiologist at Argentinian Federation of Cardiology and Argentinian Society of CArdiology. I've published original researches in local journals. I've been invited as a guest lecturer in the most Scientific Sessions of the Argentinian Federation of Cardiology since 1996. I was president of San Luis Society of Cardiology in 2007. I was a President from National Congress of Cardiology in 2014

Cardiology, Cardiovascular Diseases

Roberto Colque to date is Chief of Intensive Care Unit at Sanatorio Allende Cerro in Cordoba City, Staff of Cardiology Service at Sanatorio Allende Cerro. Past President of Cardiology Society of Cordoba. Member of Heart Failure Committee of Argentine Federation of Cardiology. Abstract reviewer of World Heart Failure Congress held in 2015 and 2016. Speakers of topics in National Heart Congress from 2010-2016 about topics of Heart Failure, Acute Heart Failure, and Coronary Syndromes. Pre grade studies made in National University of cordoba at December 1987. Residence in Cardiology at Hospital Itlaiano de Cordoba until 1991. coordinator of Coronary Unit from 1992-1994. Chief Of Coronary Unit at Italian Hospital since 1994 until 2006. Head of Cardiology Service at Clinica Velez Sarsfield 2006-2013. Post graduate activity in Hospital 12 de Octubre Madrid at Heart Failure and Transplation Unit (1993) Visitor at Buenos Aires Italian Hospital 1994 specializing on Postoperative recovery unit. Visitor at Cleveland Clinic in 1995.

Heart Failure, Heart Transplantation, Cardiology

Consultant cardiologist and Bahrain’s first interventional cardiac electrophysiologist. He is the head of electrophysiology department; cardiac pacing and tachyarrhyhmia devices in Mohammed bin Khalifa bin Salman Al Khalifa Cardiac Centre at Bahrain Defence Force Hospital. He is board certified in internal medicine and adult cardiology from University of Toronto, Canada. Subsequently he did a sub-speciality clinical fellowship in cardiac electrophysiology at Toronto General Hospital. During his cardiology residency and clinical fellowship years he did a research focusing on the “Spatial organization of ventricular fibrillation in explanted Langendorff human heart” which he presented in the annual Ursula Bangs Clinical and Research day at University of Toronto. Subsequently he presented his research at the Canadian Cardiovascular Society Meeting in Montreal/Canada and then submitted an abstract at the American Heart Association. After returning from Canada he established the country's first electrophysiology (EP) laboratory in 2010, subsequently established an advanced EP program utilizing 3D mapping system and established a program for cryoablation of atrial fibrillation. He was the past president of the Gulf Heart Rhythm Society (GHRS). He is a fellow of the Gulf Heart Rhythm Society, Fellow of The Royal College of Physicians of Canada and a Fellow of the Westminster College in Vancouver. He is an Arab Board Examiner for adult cardiology. He received the following honors and decorations; Hawar Medal of a first grade, Military Assessment Medal 1st Class and Medal of Courage. His research interests include atrial fibrillation, new oral anticoagulants, cardiac devices and sudden cardiac death.

atrial fibrillation, new oral anticoagulants, cardiac devices and sudden cardiac death

Dalin Tang received his PhD from UW-Madison in 1988. He is Professor of Mathematics and Biomedical Engineering at WPI (since 1988). He was named John E. Sinclair Professor of Mathematics in 2003-2006. He received WPI Trustee’s research award, the highest honor for faculty research at WPI. He was elected Fellow of AHA in 2011, Fellow of ASME in 2016. His research interest is image-based modeling for ventricles and vulnerable plaques. He has received 29 grants including 3 NIH R01 grants and one NSF/NIGMS grant ($1.8M). He served on various NSF, NIH, and AHA panels. AE of PLOS One and BMEO

Cardiovascular Investigations, Cardiac Magnetic resonance, Medical Engineering, Cardiac Surgery, Biomedical Engineering

Dr. Wang is a professor and the director of Department of Cardiology, Zhongnan Hospital of Wuhan University,China. He has completed his MD and PhD from Tongji Medical University, China and postdoctoral training from Germany Heart Center of Technical University of Munich, Germany and Emory University, USA. Dr. Wang has published 40 peer-reviewed papers in highly impacted journals and has been serving as an editorial board member of 3 prestigious medical journals. He has been awarded NIH R01 and R21 grants in USA and the General Project Award and the Key Project Award from the National Natural Science Foundation in China.

Arrhythmia, Electrophysiology, Heart Failure Remodeling of Heart.

Dr. Allan Jaffe graduated from the University of Maryland School of Medicine. He received his house staff and Cardiology training at Washington University and continued there for 22 years rising to the rank of Professor of Medicine. At the Mayo Clinic he is Professor of Medicine in the Cardiovascular Department and Professor and Chair of the Division of Core Clinical Laboratory Services in the Department of Laboratory Medicine and Pathology. He is an authority on biomarkers of cardiac injury, inflammation, hemodynamic disturbance, and coagulation. He is widely published and sits on most of the prestigious editorial boards and guideline committees in the Cardiology and Clinical Chemistry communities.

Coronary Heart Disease,Cardiac injury,Inflammatory Biomarkers,Acute coronary syndromes

Dr. Lerakis is a Professor of Medicine and Radiology and Imaging Sciences in the Division of Cardiology at Emory University. He is Adjunct Professor of Biomedical Engineering in Georgia Institute of Technology and Emory University. He received his M.D. degree from the Medical School of Athens (Greece) in 1988. He continued on doing clinical research in Nuclear Cardiology in Mount Sinai Medical Center in New York City. Subsequently, he did his Internal Medicine training in the Presbyterian Medical Center of Philadelphia from 1991 to 1994 and completed his Fellowship in Critical Care in Brown University from 1994 to 1995. He went on to complete his Cardiology Fellowship at the University of Texas Medical Branch in Galveston, Texas from 1995 to 1998 and then did one year of Echocardiography Fellowship at Emory University from 1998 to 1999. After his Echocardiography Fellowship, he has stayed on as Faculty in the Division of Cardiology practicing clinical and non-invasive cardiology.

Non-invasive cardiology, Coronary Artery Disease, Endocarditis, Echocardiography, Transcatheter Valvular therapies of Structural and Valvular Heart Disease, Acute myocardial infarction

Dr. Cromwell received his MD degree from the Louisiana State University School of Medicine in New Orleans, LA and completed postgraduate work in Lipid Disorders at the Washington University School of Medicine Lipid Research Center in St. Louis, MO. He is Chief of the Lipoprotein and Metabolic Disorders Institute, Discipline Director for Cardiovascular Disease at Laboratory Corporation of America (LabCorp), and Adjunct Associate Professor at Wake Forest University School of Medicine, USA. He has published over 25 book chapters and papers in journals including Lancet, Journal of the American College of Cardiology, American Journal of Cardiology, and Journal of Clinical Lipidology.

Cardiovascular Disease, Hypertension, Vascular Disease, Cardiology, Medical Research

Dr. Deepak Puri is Executive Director for Cardiac Sciences at IVY Healthcare, Mohali India. He was also the Former Director of Cardiovascular and Thoracic Surgery at Max Super Speciality Hospital at Mohali. He is a Global Chairmain for Cardiomersion and have 65 publications in International and National publications.

Cardiomersion

Dorothee H.L. Bail MD, PhD, Cardiac and Vascular Surgeon. Chief Senior Physician, Department of Vascular-, and Endovascular Surgery and Angiology, Karl-Olga-Krankenhaus, Stuttgart, Germany. She received her surgical training at the University of Tuebingen. Department of Thoracic-, Cardiac- and Vascular Surgery. Her focus is the transcatheter valve implantation, endovascular techniques and revascularization.

Heart as an endocrine organe, pathophysiology of arteriosclerosis, endovascular techniques

Ruth H. Strasser, professor, and head and chair of the Internal Medicine and Cardiology Clinic, and medical director of the Heart Centre, University Hospital, University of Technology, Dresden, Germany.

Echocardiography, Myocardial Infarction

Hermann Reichenspurner is currently the Director of the Department of Cardiovascular Surgery and Medical Director of the University Heart Center at the University Hospital Hamburg-Eppendorf. He received his surgical training at the Universities of Munich, Cape Town, South Africa, and Stanford University, USA. The University Heart Center specializes on modern and less invasive treatment of heart diseases, including endoscopic valve surgery and catheter-based operations and interventions. Another focus is the interdisciplinary treatment of patients with terminal heart and lung failure. Dr. Reichenspurner is Past President of the International Society for Heart and Lung Transplantation and the International Society for Minimally Invasive Cardiothoracic Surgery.

Heart and Lung Transplantation & Invasive Cardiothoracic Surgery

Giuseppe Di Pasquale has his expertise in Division of Cardiology. He is currently the Director of the Division of Cardiology of the Maggiore Hospital, Bologna, Italy. He were president of several Italian Scientific Societies: Cardiological Italian Working Group “Atherosclerosis, Thrombosis and Vascular Biology” for 2000-2003; Italian Association of Hospital Cardiologists (ANMCO) for 2004-2006; Italian Federation of Cardiology (FIC) for 2007-2010; The Italian Stroke Forum for 2011-2013. He has published 450 scientific publications (impact factor 550; H index 31) and 4 books. He is the Member of the Scientific Board and referee for numerous national and international Journals of cardiology and vascular neurology, Member of the Steering Committee of multicenter clinical studies and of International Advisory Boards on atrial fibrillation, thrombosis, and heart failure. Speaker at more than 950 scientific appointments consisting of national and international congresses.

Cardiology, Heart Failure, Vascular Biology, Atherosclerosis, Thrombosis

Dr Fausto Rigo, FESC is the Head of Division of Cardiology in dell Angelo Hospital, Mestre-venice Italy. And director of UOC cardiology in Ospedale dell Angelo.

Cardiology Hypothermia, Positron Emission Tomography, Cardiovascular Interventions

Gino Gerosa is Professor of Cardiac Surgery at the University of Padova Medical School. He is currently Chief of the Cardiac Surgery Division. and Director of the heart transplant and mechanical circulatory support programme at Padova University Hospital. Professor Gerosa performed the first Italian robot enhanced coronary bypass on beating heart in 2001 and one of the first worldwide stem cell transplantation for post-ischemic cardiomiopathy in 2002.He also performed the first italian implantation of the Cardiowest TAH in 2007 and the first in man implantation of a complete mitral ring off pump on beating heart in 2016. He is a member of the Italian Society of Cardiac Surgery, EACTS and AATS. He is coauthor of more than 350 publications and several book’s chapters.

Cardiac Surgery, Cardiomiopathy

Stephan B. Felix is chairman of the Department of Internal Medicine B, University Medicine Greifswald, Germany. He focuses on basic and clinical research on the disturbances of the cellular and humoral immune system in heart failure and inflammatory cardiomyopathy. Thereby novel methods of immunoprofiling, molecular biology, nanotechnology, and OMICs technologies are applied for studies of the pathophysiology of inflammatory cardiomyopathy, dilated cardiomyopathy, and heart failure development. In addition, clinical studies are performed with interventions in the immune system of patients with dilated and inflammatory cardiomyopathy. also performs preclinical and clinical studies on diagnosis and treatment of acute and chronic heart failure. In the field of epidemiology and studies with patient cohorts he is involved in characterization of cardiovascular risk factors and cardiovascular diseases by means of molecular genetics and deep molecular phenotyping.

Cellular and humoral immune system in heart failure, Inflammatory cardiomyopathy and Heart failure development

Otto A. Smiseth is Professor and Head, Division of Cardiovascular and Pulmonary Diseases at Oslo University Hospital. He is Past Chair European Society of Cardiology Education Committee. Dr. Smiseth is specialist in Cardiology and has training from Norway, San Francisco USA and Calgary and Vancouver, Canada. His main research interests are pathophysiology of heart failure with preserved left ventricular ejection fraction, heart failure due to left ventricular dyssynchrony and cardiac imaging.

Pathophysiology of heart failure with preserved left ventricular ejection fraction, heart failure due to left ventricular dyssynchrony and cardiac imaging

Louis Boisanté was former head of clinic-assistant of the hospitals of Paris. He was Former Chief of the Department of Internal Medicine, Niedercorn Hospital, Luxembourg. He worked as Former guideline coordinator for the European Society of Cardiology and also a Member of the French, Luxembourg and European societies of cardiology. He served as Member of the ethic commission of the French Society of Cardiology. He was Vice President of the Medical Section of the Chamber of expert in Luxembourg.

Cardiology

Graduated in Medicine from Universidade Federal Fluminense in 1980; Fellowship in Medical Clinic in 1981/82 and in Cardiology in 1982/84 at Hospital Naval Marcílio Dias; Specialist in Cardiology from the Brazilian Society of Cardiology in 1992; Civil physicist in the navy since 1985 and the city Hall of Rio de Janeiro since 1987; Researcher from CNPq in 1981, 1987/89; President of CMS Necker Pinto Study Center in 1996; Mastership in Cardiology by Universidade Federal Fluminense in 2001; Advanced Cardiovascular Life Support Course by the Brazilian Society of Cardiology and American Heart Association in 2001 and 2005. Awards: "Academia Nacional de Medicina/Amil" in 2004, 2005 and 2011, and "ABRAMGE de Medicina" in 2004. Certificate from Cleveland Clinic as an international visitor doctor in the Dept: Nuclear Medicine in june of 2005 (USA). International visitor doctor in the Harley Street Healthcare Clinic and Chase Farm Hospital in London in July of 2006 (UK). PhD in Cardiology by Universidade Federal do Rio de Janeiro in 2012.

Cardiology

Dr. M Reza Movahed received his MD from Medizinische Hochschule Hannover, Germany Residency at U of Rochester, his cardiology training at U of South Caroline, and interventional cardiology at Yale University. He is Clinical Professor of Medicine at the University of Arizona. He has over 200 peer reviewed publications. He has been Director of Cath lab and Nuclear Cardiology at UC Irvine and Director of Coronary Care Unit and Medical Director of Cardiac Transplantation at the U of Arizona. In May 2012, he was appointed as CareMore Regional Cardiology Director. He is world-renowned for his coronary bifurcation classification known as “The Movahed Classification”, for “ Movahed’s sign” for RV overload and reverse “Movahed Maneuver for improvement of stent deliverability in vein grafts. He has patent for a device for removal of contrast from coronary sinus and a device that can measure cross sectional lumen of a vessel.

Nuclear Cardiology, Cardiac Transplantation, coronary sinus

Dr Cappato is Principal Investigator for X-VERT (eXploring the efficacy and safety of oral rivaroxaban OD compared with that of dose-adjusted oral VKA for the prEvention of caRdiovascular events in patients with non-valvular aTrial fibrillation scheduled for cardioversion) and VENTURE-AF (randomized, open-label, actiVe-controlled multi-cENTer stUdy to evaluate the safety of Rivaroxaban and vitamin K antagonists in subjects undergoing cathEter ablation for Atrial Fibrillation) studies. Dr Cappato is also leading investigator of a patient-based worldwide atrial fibrillation ablation survey. He is the co-inventor of the sub-cutaneous implantable cardioverter defibrillator. He frequently serves as an invited speaker at major international meetings. He has published over 300 peer-reviewed journals and book chapters, and is on the editorial board of numerous Cardiology Journals.

Supraventricular and ventricular arrhythmias, Transcatheter radio-frequency

Mario MARZILLI has been Professor and Chairman of the Division of Cardiovascular Medicine at the Cardiothoracic Department of Pisa University Medical School (Italy) since 2007. He is also Director of the Post-Graduate School of Cardiovascular Medicine at the University of Pisa (from 2010). Mario Marzilli graduated in Medicine and Surgery with full honors at Pisa University Medical School in 1971 and started as a Research Fellow of the Italian National Research Council in Pisa. He began his academic career as Assistant Professor of Medicine at the Pisa University Medical School in 1977 and progressed to Associate Professor of Clinical Physiology and Internal Medicine in 1986. From 2000 to 2006, Professor Marzilli was Full Professor of Cardiovascular Medicine and Chairman of the Postgraduate School of Cardiology at the University of Siena, and visiting Professor of Cardiovascular Research at the Henry Ford Hospital, Detroit (Michigan, USA) in the years 1977-78. Mario Marzilli is a member of several scientific societies, including the Societa Italiana di Cardiologia, European Society of Cardiology, American College of Cardiology, and the American Heart Association. His research is focused on coronary pathophysiology, interventional cardiology, ischemic heart disease, acute myocardial infarction, clinical pharmacology and hypertension. He has published more than 450 scien-tific papers and has edited books on invasive cardiology, coronary physi-ology, and cardiovascular therapy. Professor Marzilli reviews papers submitted for publication to Italian Heart Journal, European Heart Journal, Heart, Journal of the American Col-lege of Cardiology, Circulation, Basic Research in Cardiology, International Journal of Cardiology, and American Journal of Cardiovascular Drugs.

Cardiothoracic, Cardiovascular Medicine, Clinical Physiology, invasive cardiology

Stefano Ghio obtained his medical degree (cum laude) from the University of Pavia School of Medicine at 23 years-old in 1982, and specialised in Cardiology at the University of Pavia School of Medicine, Pavia in 1987. Since then, he has been working in the Division of Cardiology of Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. Currently, he is chief of the Heart Failure and Pulmonary Hypertension Unit. Dr Ghio has authored or co-authored more than 170 papers in indexed medical journals including topics such as pulmonary hypertension, cardiac resynchronisation therapy, cardiac imaging techniques in heart failure and cardiomyopathies. Dr Ghio is the coordinator of a regional network on pulmonary arterial hypertension in Regione Lombardia, Italy. Dr Ghio is Fellow of the European Society of Cardiology since 1991.

Cardiology, Heart Failure, Pulmonary Hypertension, Cardiomyopathies, Cardiac Resynchronisation Therapy, Cardiac Imaging Techniques

Prof. Ehud Goldhammer has his expertise in exercise physiology and cardiac rehabilitation, and heart failure patient's rehabilitation in particular. His passion for improving the health and wellbeing of coronary artery patients led him to establish (1982) the first cardiac rehabilitation center in the northern part of Israel, encouraging women, elderly, old people, and minorities to join cardiac rehabilitation programs. Since the establishment of this cardiac rehabilitation center, he tried to promote exercise programs for heart failure patients. Prior to the late 1980s, cardiac enlargement, decreased left ventricular systolic function and heart failure were considered absolute or relative contraindications to exercise training, however he tried already in the early 1980s to persuade cardiologists and general practitioners to refer heart failure patients to exercise programs in contrast to previous treatment strategies that involved restriction of physical activity and bed rest for all stages and forms of heart failure.

Cardiac rehabilitation, Heart failure, Exercise Physiology

Marco Picichè (MD, Ph.D.) graduated with a degree in medicine from the University of Florence in 1995 and completed his cardiac surgery residency at the Tor Vergata University of Rome in 2000, both summa cum laude. He held regular teaching appointments at the university of Montpellier school of medicine, obtained certification by the French Board in cardiac surgery (Paris, 2007), earned his research master in surgical science (Paris, 2007), and received a university diploma in vascular surgery (Paris, 2007). In May 2009 he had the honor of opening the 44th Congress of the European Society for Surgical Research with a lecture on ‘‘The history of surgical research.’’ In September 2011 he received a doctor of philosophy (Ph.D.) in therapeutic innovations from Paris-Sud University. He is the Editor in Chief of the book : « Dawn and evolution of cardiac procedures : research avenues in cardiac surgery and interventional cardiology » (Springer-Verlag publishing house, September 2012). He patented a new surgical instrument. Currently he is a cardiac surgeon in Italy.

Cardiac surgery, Interventional cardiology

Amir A. Sepehri has received his B.S.E.E. from Auburn University, USA and his PhD from ‘faculté polytechnique de mons’ (Mons University, Belgium), on digital audio signal processing. He has worked on a special research program on ‘Computerized Screening of Congenital Heart Disease’ for 16 years. The program was aimed toward obtaining a special diploma known as ‘l’Agrégation de l'Enseignement Supérieur’ in the same university. The result of his research work is formulated as Arash-Band method and it is internationally patented. Based on Arash-Band method: unique processing method in murmur characterization, a robust device for automated screening of children’s congenital heart diseases, known as POUYA-Heart is developed and it is now available as a diagnostic medical device. POUYA-Heart is the first Intelligent phonocardiograph for CHD and CCHD screening. He has several publications on congenital heart diseases screening, detection and cardiac murmurs. He is currently director of CAPIS biomedical R&D department.

Congenital heart diseases.

Walid M Hassan is the Director in Cardiovascular Center of Excellence International Medical Center Jeddah, Saudi Arabia (November 2012- Present). He is the Consultant Interventional Cardiology Virginia Cardiovascular Center (January 2015-present). He is the Editorial Board and Reviewer for 35 International Journals 600 Published Articles/ Abstracts/ Presentations.

Cardiovascular Medicine, Interventional Cardiology

Zdeněk Gütter, PhD has his expertise in healthcare innovations based on information and communication technologies including eHealth with main focus on cardiology. This covers tools for assessment of technologies and telemedicine services, implementation and evaluation of impacts. He is particularly involved in research in the area of telemedicine applied to healthcare of patients with chronic diseases, including heart failure. He coordinates programs and EU projects for the Czech National eHealth Center (NTMC) of the University Hospital Olomouc (UHO).

Cardiology Healthcare Innovations.